D&D Pharmatech's New Drug Candidate Approved for Phase 2 Clinical Trial in Multiple Sclerosis in the U.S.
The U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for the Phase…
NLY01
1 개의 기사가 있습니다.